- Home
- AARD vs OWLT Comparison
AARD vs OWLT Comparison
Compare AARD & OWLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AARD | OWLT |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.8M | 155.2M |
| IPO Year | 2025 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AARD | OWLT |
|---|---|---|
| Price | $7.21 | $5.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $15.29 | ★ $17.50 |
| AVG Volume (30 Days) | ★ 137.9K | 115.4K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 43.11 | ★ 65.34 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $105,708,000.00 |
| Revenue This Year | N/A | $22.81 |
| Revenue Next Year | N/A | $20.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 35.43 |
| 52 Week Low | $3.35 | $4.19 |
| 52 Week High | $17.94 | $16.94 |
Technical Indicators
Market Signals| Indicator | AARD | OWLT |
|---|---|---|
| Relative Strength Index (RSI) | 54.73 | 53.83 |
| Support Level | $4.99 | $5.18 |
| Resistance Level | $7.92 | $6.23 |
| Average True Range (ATR) | 0.71 | 0.30 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 60.28 | 90.11 |
Price Performance
Historical ComparisonAbout AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About OWLT Owlet Inc.
Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.